Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.

Author: CohnMartin, EreshefskyLarry, FeldmanNeil, HullSteven, LankfordAlan, MaylebenDavid, RogowskiRoberta, RothThomas, ScharfMartin

Paper Details 
Original Abstract of the Article :
OBJECTIVES: Evaluate efficacy and safety of the histamine-H1 antagonist doxepin at doses of 1 mg, 3 mg, and 6 mg in elderly adults with primary insomnia. DESIGN: A randomized, double-blind, placebo-controlled, crossover design was used in this population of elderly adults with primary insomnia (DSM...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.4088/jcp.v69n1005

データ提供:米国国立医学図書館(NLM)

Doxepin: A Potential Oasis in the Desert of Insomnia

Sleep research is a vast and often sandy desert, filled with challenges. We're always searching for effective treatments for those struggling with sleep disorders. This study dives deep into the effects of doxepin, a histamine-H1 antagonist, on elderly adults with primary insomnia. It's like finding a hidden spring in the desert! The researchers used a randomized, double-blind, placebo-controlled, crossover design, a rigorous approach that helps ensure reliable results. They tested different doses of doxepin and compared them to a placebo. Their findings were like a cool breeze on a hot day - they found that all three doses of doxepin significantly improved sleep quality in the elderly participants compared to the placebo.

Doxepin Shows Promise for Better Sleep

This research suggests that doxepin can be an effective treatment for sleep maintenance and duration in elderly adults with primary insomnia. All three doses improved objective and subjective sleep quality, even in the final hour of the night. The highest dose even showed positive effects on patient-reported sleep onset, a significant finding. This is a huge step forward in helping our elderly population get a good night's rest.

A Beacon of Hope for a Restful Night

This study offers hope for those struggling with insomnia. The positive effects of doxepin, coupled with its safety profile comparable to placebo, make it a promising treatment option. It's like finding a hidden oasis in the desert - providing comfort and relief after a long, arduous journey.

Dr.Camel's Conclusion

The results of this study are truly exciting. It's fantastic to see a safe and effective treatment option for insomnia, especially in elderly individuals. While further research is always crucial, this study shines a light on the potential of doxepin to improve sleep and overall well-being. It's a beacon of hope for those navigating the sometimes-restless desert of insomnia.

Date :
  1. Date Completed 2009-03-05
  2. Date Revised 2019-09-02
Further Info :

Pubmed ID

19192438

DOI: Digital Object Identifier

10.4088/jcp.v69n1005

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.